Company Opko Health Inc. TEL AVIV STOCK EXCHANGE

Equities

US68375N1037

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical & Diagnostic Laboratories

Inactive Instrument

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.

USD in Million	2022	Weight	2023	Weight	Delta
Diagnostics 59.7 %	756	75.2 %	515	59.7 %	-31.81%
Pharmaceutical 40.3 %	249	24.8 %	348	40.3 %	+40.09%

USD in Million	2022	Weight	2023	Weight	Delta
United States 69.2 %	783	78.0 %	598	69.2 %	-23.67%
Ireland 16.4 %	117	11.7 %	141	16.4 %	+20.69%
Chile 7.9 %	62	6.2 %	68	7.9 %	+10.39%
Spain 2.7 %	22	2.2 %	24	2.7 %	+4.63%
Mexico 2.3 %	15	1.4 %	20	2.3 %	+38.98%
Israel 1.1 %	4	0.4 %	10	1.1 %	+153.26%
Other 0.3 %	1	0.1 %	2	0.3 %	+160.25%

Managers	Title	Age	Since
Phillip Frost CEO	Chief Executive Officer	87	26/03/07
Adam Logal DFI	Director of Finance/CFO	46	28/02/07
Elias Zerhouni PSD	President	72	08/05/22
Elizabeth Nabel CTO	Chief Tech/Sci/R&D Officer	72	30/04/22
Jane Hsaio CTO	Chief Tech/Sci/R&D Officer	77	31/01/07
Steven Rubin ADM	Chief Administrative Officer	63	31/01/07
Gary Nabel BRD	Director/Board Member	70	08/05/22
Jane Pine Wood LAW	General Counsel	-	-
Stephen A. Strugnell PRN	Corporate Officer/Principal	-	08/04/14

Members of the board	Title	Age	Since
Phillip Frost CEO	Chief Executive Officer	87	26/03/07
Roger Medel BRD	Director/Board Member	77	17/12/20
Richard Pfenniger BRD	Director/Board Member	68	31/12/07
Steven Rubin ADM	Chief Administrative Officer	63	31/01/07
Lin-Tsing Yu BRD	Director/Board Member	80	22/04/09
Jane Hsaio CTO	Chief Tech/Sci/R&D Officer	77	31/01/07
John Paganelli BRD	Director/Board Member	89	30/11/03
Richard Krasno BRD	Director/Board Member	82	08/02/17
Elias Zerhouni PSD	President	72	08/05/22
Gary Nabel BRD	Director/Board Member	70	08/05/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	726,764,430	331,723,053 ( 45.64 %)	29,772,753 ( 4.097 %)	45.64 %

Name	Equities	%	Valuation
Phillip Frost 35.07 %	244,428,350	35.07 %	298 M ILa
Elias Zerhouni 5.846 %	40,745,228	5.846 %	50 M ILa
Jane Hsaio 4.753 %	33,127,284	4.753 %	40 M ILa
BlackRock Advisors LLC 4.481 %	31,230,701	4.481 %	38 M ILa
Vanguard Fiduciary Trust Co. 4.233 %	29,501,231	4.233 %	36 M ILa
Gary Nabel 2.945 %	20,526,980	2.945 %	25 M ILa
Elizabeth Nabel 2.857 %	19,912,459	2.857 %	24 M ILa
STATE STREET CORPORATION 1.464 %	10,202,528	1.464 %	12 M ILa
Geode Capital Management LLC 1.431 %	9,971,554	1.431 %	12 M ILa
KSM Mutual Funds Ltd. 1.329 %	9,262,183	1.329 %	11 M ILa

Name	Equities	%	Valuation
GENEDX HOLDINGS CORP. 13.66%	3,558,601	13.66%	39,749,573 $

OPKO Health, Inc.

4400 Biscayne Boulevard

33137, Miami

+305-575-4100

http://www.opko.com

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-25.19%	7.67B
RADNET, INC.	+70.72%	4.38B
DR. LAL PATHLABS LIMITED	+1.91%	2.64B
SYNLAB AG	-7.36%	2.52B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-44.46%	2.23B
NEOGENOMICS, INC.	-14.65%	1.77B
FLEURY S.A.	-21.62%	1.52B
METROPOLIS HEALTHCARE LIMITED	+17.46%	1.21B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.89%	1.14B

Medical & Diagnostic Laboratories